1. Home
  2. INDI vs ANL Comparison

INDI vs ANL Comparison

Compare INDI & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo indie Semiconductor Inc.

INDI

indie Semiconductor Inc.

HOLD

Current Price

$4.13

Market Cap

750.1M

Sector

Technology

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$10.70

Market Cap

611.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDI
ANL
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
750.1M
611.1M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
INDI
ANL
Price
$4.13
$10.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$6.25
$20.00
AVG Volume (30 Days)
6.3M
154.9K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
3.95
N/A
EPS
N/A
N/A
Revenue
$217,394,000.00
N/A
Revenue This Year
$25.54
$36.02
Revenue Next Year
$38.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.33
N/A
52 Week Low
$2.32
$0.88
52 Week High
$6.05
$17.25

Technical Indicators

Market Signals
Indicator
INDI
ANL
Relative Strength Index (RSI) 49.39 49.37
Support Level $4.03 $6.92
Resistance Level $4.77 $12.32
Average True Range (ATR) 0.40 1.40
MACD 0.06 0.09
Stochastic Oscillator 51.36 64.88

Price Performance

Historical Comparison
INDI
ANL

About INDI indie Semiconductor Inc.

Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: